Letter

An emerging problem

Urinary tract disease associated with chronic ketamine use

BMJ 2008; 336 doi: 10.1136/bmj.39562.711713.80 (Published 1 May 2008)
Cite this as: BMJ 2008;336:973.1

This article has a correction

Please see: Urinary tract disease associated with chronic ketamine use

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Angela M Cottrell, clinical research fellow1,
  2. Rachel Athreeres, volunteer manager2,
  3. Pete Weinstock, senior practitioner2,
  4. Kate Warren, urology registrar3,
  5. David Gillatt, consultant urological surgeon4
  1. 1Bristol Urological Institute, Southmead Hospital, Bristol BS10 5NB
  2. 2Bristol Drug Project, Bristol BS2 8PE
  3. 3Weston General Hospital, Weston super Mare BS23 4TQ
  4. 4Bristol Urological Institute, Bristol
  1. angecottrell{at}hotmail.com

    Regarding the case study by Dhillon et al,1 we have seen an alarming increase in people presenting to urological services in South West England with bladder symptoms associated with chronic ketamine use. Two case series in Hong Kong and Canada have been published, but ketamine associated bladder pathology has not been reported in the UK.2 3

    Over the past two years, nine …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular